HIC is the health conference to attend - the absolute cutting edge in health information

Personalised Medicine
Conference 2013

15 July 2013 Adelaide Convention Centre


The Health Informatics Society of Australia (HISA) is pleased to invite you to participate in the inaugural Personalised Medicine (PM) Conference to be held on 15 July 2013 at the Adelaide Convention Centre.

The primary theme of PM 2013 is The Role of Informatics in Delivering Personalised Medicine.

The inaugural HISA Personalised Medicine (PM) conference is honoured to be co-chaired by Prof Richard Cotton and Prof Fernando Martin-Sanchez. The impressive line-up of national and international keynotes will address the role of informatics in delivering the future of personalised medicine.

Personalised medicine will have a significant impact on, and change the very nature of healthcare, the practice of medicine and how we live. The promise of personalised medicine has challenges and opportunities which health informatics must address as we continue to play a crucial role in this exciting space. The conference will cover the topics of data generation, integrating molecular and clinical data, analysing and visualising information and turning molecular information into medically actionable knowledge.


Platinum Sponsor

Oracle enables the convergence of the life sciences and healthcare industries with solutions that improve the quality of care, lower costs, and speed time to market.


David Amor trained in paediatrics at the Royal Childrens Hospital before joining the Victorian Clinical Genetics Service in 1998. In 2004 David completed a PhD in Chromosome Biology at the Murdoch Childrens Research Institute and since that time has worked as a clinical geneticist based at RCH, Melbourne IVF, and in Tasmania. His current research focuses on the identification of genes for rare syndromes, and genetic factors related to infertility and IVF treatment. In 2010 David was appointed Director of the Victorian Clinical Genetics Services.

Prof Richard Cotton AM initiated the Mutation Research Centre, now renamed the Genomic Disorders Research Centre, in January, 1996 (www.genomic.unimelb.edu.au). He has always been interested in the biochemical genetics of human disease and has recently focussed on mutation. In 1992, he initiated the journal Human Mutation. In June 2005, he was admitted as a Member of the Order of Australia for service to science through genetic research, particularly through the development of technologies to detect gene mutations that underlie birth defects or cause disease and through efforts to document findings. In June 2006, he convened a Meeting, co-sponsored by WHO, which initiated the Human Variome Project (HVP; www.humanvariomeproject.org). The Human Variome Project has recently been given the status of NGO official partner of UNESCO (consultative status). Richard is the Director of the Australian Node of Human Variome Project until December 2012 and is currently the Scientific Director of Human Variome Project. He is also the Co-Editor of Human Mutation.

Dr William (Bill) S. Dalton is past President, CEO & Center Director of Moffitt Cancer Center. He is currently Founder and CEO of M2Gen, a national biotechnology subsidiary of Moffitt Cancer Center. Dr Dalton is interested in the development of personalised cancer care and patient-centered outcomes approach to developing evidence-based, personalised cancer treatments and information/decision tools for patients and clinicians. His interests include developing an integrated system that allows for the creation and understanding of phenotypic and genotypic information to match patients to the most appropriate therapies.

Dr Robert Fassett As Oracle’s CMIO Rob is responsible for channeling Oracle’s healthcare R&D investments into the development of new products and services that will help providers and life sciences companies transform the practice of medicine. Most recently Rob created, and then led the development and marketing of, Oracle’s enterprise healthcare data warehousing and analytics suite of products that have been acquired by nearly 100 hospitals. Before joining Oracle, Rob founded speech recognition software company that was acquired by Oracle. Rob was also a co-founder of a gene therapy startup and has served as a consultant and scientific advisor to several biotech companies. Rob is a primary care physician and graduate of UCLA School of Medicine. Rob received his undergraduate degree in molecular biology at UCSD.

A/Prof Clara Gaff Clara Gaff is a genetic counsellor who is currently working on the collaborative development of genomics and personalised medicine in Parkville and across the Victorian Comprehensive Cancer Centre. She has an honorary appointment at the University of Melbourne, with research interests in education, consent and communication of genetic information. She is a member of the NHMRC Human Genetics Advisory Committee.

Dr Stefan Harrer Stefan holds B.Sc., Diploma, and Ph.D. degrees in EECS from the Technical University Munich and an Honors Masters Certificate in technology management from the Technical University Munich and the Ludwig-Maximilians University Munich. He was a Visiting Graduate Student at the Massachusetts Institute of Technology before he joined IBM Research as a process engineer in the Advanced Lithography Group, Albany, USA. He then became a research scientist in the IBM T. J. Watson Research Center, Yorktown Heights, USA. He is currently the Lead of BioNanotechnology Research in the IBM Australia Research Laboratory and also an Honorary Associate Professor at the University of Melbourne.

Karin Kassahn is a medical scientist with 10 years research experience in biological and biomedical sciences. Since 2009 she has been an active member of the International Cancer Genome Consortium where her research has focused on somatic mutation detection from next-generation sequencing (NGS). In 2013 she took up the position of Head of Technology Advancement, SA Pathology to implement NGS in clinical diagnostics and patient management.

A/Prof Andrew Lonie is a faculty member of the department of Computing and Information Systems at the University of Melbourne and foundation head of the Life Sciences Computation Centre, a cross-institutional centre of bioinformatics and computational biology expertise and infrastructure support within the Victorian Life Sciences Computation Initiative. A/Prof Lonie is also academic coordinator of the MSc (Bioinformatics) at the University of Melbourne.

Professor Martin-Sanchez is a biomedical information scientist. He is the foundational Chair of Health Informatics at the University of Melbourne's Medical School. A former director of a world-renowned laboratory in Medical Bioinformatics at the National Institute of Health of Spain, he played a key role in promoting research on Biomedical Informatics across the European Commission VI and VII Framework Programmes.

Graeme Suthers trained in clinical and laboratory genetics in Sydney, Adelaide, and Oxford. He is currently Head of the South Australian Clinical Genetics Service, and Chair of the Genetics Advisory Committee of the RCPA. He is a member of the Medical Services Advisory Committee of the Australian Department of Health & Ageing, and of the Australian Government’s Genetics Working Party.

Prof Graham Taylor joined the Department of Pathology at Melbourne University as the Herman Professor of Genomic Medicine and Director of the Australian node of the Human Variome Project in 2012. His current interests are the development of diagnostic applications and data pipelines for Next Generation Sequencing (NGS), including the targeted re-sequencing for the diagnosis of genetic disease, the use of NGS is tumour profiling for stratified medicine and the development of secure means data sharing.

Richard Tothill is genomicist and cancer researcher at the Peter MacCallum Cancer Centre in Melbourne with more than 13 years experience in the application of genomic technologies to cancer research. In recent years he has managed the Peter Mac next-generation sequencing facility and has played a leading role in the development of sequencing pipelines for research and clinical applications.

Paul Waring trained as an anatomical pathologist at the QEII Medical Centre in Perth, undertook a PhD at the Walter and Eliza Hall Institute and a post - doctoral fellowship in Molecular Pathology at Stanford University. His past appointments include: Director of Pathology at the Peter MacCallum Cancer Centre (2001-04), Sr. Director of Pathology and Diagnostics at Genentech Inc, USA (2004-2008). In March 2010, he was appointed as Chair in Pathology at The University of Melbourne. His current interests include the use of biomarkers to select patients for new targeted anti-cancer therapies.


Registration is now open for PM 2013.

You can register to attend the day or purchase a full conference registration to HIC 2013 and your attendance at one of the associated events on Monday 15 July is included.


Personalised Medicine Conference
HISA Member* $310
HISA Non-member $360
Student § $155

* HISA Member rate applies to current HISA members (excludes Affiliate members. Please contact hic2013@hisa.org.au if you are an Affiliate member).

§ Student registration must be accompanied by proof of valid full time University student ID. Please email to hic2013@hisa.org.au or fax to +61 3 8610 0006. Student registration does not include the Gala Dinner.

Registration Cancellation Policy

Strategic Advisory Committee

Prof Richard Cotton PM 2013 Conference Co-Chair, Director, Human Variome Project
Prof Fernando Martin-Sanchez PM 2013 Conference Co-Chair, Chair of Health Informatics, Melbourne Medical School, The University of Melbourne
A/Prof Clara Gaff Honorary - Medicine, The University of Melbourne
Dr Louise Schaper CEO, HISA
Prof Paul Waring Chair of Pathology, The University of Melbourne

Associated events
Platinum Sponsors

Gold Sponsor

Silver Sponsors

Delegate Lounge Sponsor

Lanyard and NIA Networking Reception Sponsor


Speaker Sponsor


Workshop Session Sponsor